National use of trimethoprim and sulphamethoxazole for one year--problems and solutions.
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000188:drug therapy; D002006:Brucellosis / Q000188:drug therapy; D004357:Drug Synergism; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012189:Retrospective Studies; D012480:Salmonella Infections / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014069:Tonsillitis / Q000188:drug therapy; D006113:United Kingdom; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D011743:Pyrimidines; D013420:Sulfamethoxazole